Avicularin Attenuates Memory Impairment in Rats with Amyloid Beta-Induced Alzheimer’s Disease
- 18 January 2022
- journal article
- research article
- Published by Springer Nature in Neurotoxicity Research
- Vol. 40 (1) , 140-153
Abstract
Amyloid-beta-induced Alzheimer’s disease (AD) and its further complications are well-established models in preclinical studies and demonstrated by many researchers. Intracerebroventricular injection of Aβ produces brain malfunction, including neurodegeneration and memory impairment. Avicularin is a bioactive flavonoid that has been found to prevent oxidative stress and proinflammatory cytokines. Alzheimer’s disease treatment may benefit from inhibiting amyloid-beta and its related complications. Hence, by considering multiple actions of avicularin, including antioxidant and anti-inflammatory, we demonstrated the neuroprotective action of avicularin against amyloid beta-induced neurotoxicity. Aβ1–42 (1 µg/µl) was dissolved in phosphate buffer solution (pH7.4) and incubated at 37 °C for 3 days to induce aggregation. A single intracerebroventricular (i.c.v.) injection of the Aβ1-42 was given to the animals utilizing stereotaxic equipment. Avicularin was dissolved in 0.5% sodium carboxymethyl cellulose (CMC), and treatment was given to the animals for 21 days at a dose of (25, 50, and 100 mg/kg, p.o.) after Aβ1-42 peptide (i.c.v.) injection. Several behavioral studies, acetylcholinesterase activity, oxidative stress, TNFα, IL-6, IL-1β, and expression of BDNF and amyloid-beta were measured. Avicularin treatment (50 and 100 mg/kg) showed cognition enhancement activity in behavioral studies and could reverse the effects of amyloid beta-induced inflammatory response and excessive oxidative stress. Furthermore, the findings reveal that avicularin can halt AD progression by targeting BDNF and amyloid-beta levels in the brain, suggesting that avicularin could be used for Alzheimer’s disease treatment.Keywords
This publication has 38 references indexed in Scilit:
- Behavioral profile of mice with impaired cognition in the elevated plus-maze due to a deficiency in neural cell adhesion moleculePharmacology Biochemistry and Behavior, 2010
- Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5Neuron, 2010
- Cannabinoid receptor ligands suppress memory-related effects of nicotine in the elevated plus maze test in miceBehavioural Brain Research, 2008
- Morris water maze: procedures for assessing spatial and related forms of learning and memoryNature Protocols, 2006
- Antioxidant Activity of a Flavonoid-Rich Extract ofHypericum perforatumL.in VitroJournal of Agricultural and Food Chemistry, 2004
- Immunohistochemical Visualization of Brain‐derived Neurotrophic Factor in the Rat BrainEuropean Journal of Neuroscience, 1995
- Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and miceProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1992
- Developments of a water-maze procedure for studying spatial learning in the ratJournal of Neuroscience Methods, 1984
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961
- Tissue sulfhydryl groupsArchives of Biochemistry and Biophysics, 1959